Our latest news, documents and media coverage

Press releases

Presymptom Health’s latest news

Media coverage

Coverage on sepsis and AMR

Video

Relevant videos on sepsis and AMR

Company brochure

Our latest company brochure

Press releases

After more than five years of dedicated leadership at Presymptom Health, our CEO, lain Miller, will be moving on to new opportunities at the end of June 2025.

We are pleased to announce that Nadia Whittley will be stepping into the role of Chief Executive Officer, effective immediately. Nadia brings over 20 years of experience in our industry to this position.

UK MedTech Presymptom Health secures additional £200k in grant funding

The grant funding will be used by UK MedTech Presymptom Health to speed-up its AI-driven infection detection technology,
cutting test times to just 40-60 minutes.

UK medtech company Presymptom Health has announced positive results from its clinical trial (PRECISiON)

Breakthrough infection test designed to tackle antimicrobial resistance is on target for 2025
UK NHS availability after positive trial results

MoD spin-out raises £1.5m to develop AI

MoD spin-out Presymptom Health raises £1.5m to develop AI-driven sepsis and infection tests for the NHS

Presymptom Health joins government pilot

Presymptom Health joins government pilot to get AI-driven infection test into the NHS faster

Presymptom Health welcomes…

Presymptom Health welcomes Nadia Whittley as a Non-Executive Director, accomplished senior executive

Pioneering sepsis

Funding from Ploughshare Innovations and UK Innovation & Science Seed Fund will enable the company to complete clinical trials.

Presymptom Health receives additional funding

Presymptom Health Receives Additional Funding to Support its Trials of an Early Test for Sepsis

Portsmouth’s Queen Alexandra Hospital trials

Queen Alexandra Hospital trials test that could reduce burden on NHS by predicting sepsis in patients

Predictive Sepsis Test
to save lives

A revolutionary test to predict which COVID-19 patients will develop sepsis, before symptoms appear

Media coverage

UK defence IP is helping an AI health startup accelerate infection diagnosis

The UK’s Presymptom Health was borne out of an MoD study with a view to commercialising AI-based infection research.

How Ploughshare spin-out Presymptom Health is using UK defence AI

The healthcare startup was spun out of the MoD-owned entity with a view to commercialising AI-based infection research.

The Role of AI in tackling sepsis and AMR

Dr Iain Miller (Presymptom Health) and Dr Mark Gostock (Ploughshare) talk about the role of AI, full discussion in the June 24 issue of the Clinical Services Journal.

World Antimicrobial Resistance Week 2023

World Antimicrobial Resistance Week is an important awareness and educational campaign. As a member of ABHI we are delighted to support this initiative.

Sepsis often missed as 50% of screening tools don’t work

Paramedics and A&E doctors often miss signs of sepsis and two of the four ways health professionals screen for the killer condition do not work, a new study claims.

Innovation to Impact

Presymptom Health is featured in the Ploughshare Review 2022, pages 8-9.

Video

Supporting antimicrobial stewardship by enabling the early diagnosis of infection and sepsis.

Supporting antimicrobial stewardship by enabling the early diagnosis of infection and sepsis.

Presymptom Health was founded in 2019 to develop a novel technology that addresses two growing global healthcare challenges: early infection diagnosis and antimicrobial resistance (AMR). Download the company brochure.